Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
0(0%)
Results Posted
43%(3 trials)
Terminated
1(13%)

Phase Distribution

Ph phase_2
3
38%
Ph not_applicable
2
25%
Ph phase_1
2
25%
Ph phase_4
1
13%

Phase Distribution

2

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
2(25.0%)
Phase 2Efficacy & side effects
3(37.5%)
Phase 4Post-market surveillance
1(12.5%)
N/ANon-phased studies
2(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(7)
Terminated(1)

Detailed Status

Completed7
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
87.5%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (25.0%)
Phase 23 (37.5%)
Phase 41 (12.5%)
N/A2 (25.0%)

Trials by Status

completed788%
terminated113%

Recent Activity

0 active trials
Showing 5 of 8
completedphase_4

Clinical and Imaging Trial of Uridine for Veterans With Suicidal Ideation

NCT03265964
completedphase_2

Oral Uridine for Treatment of Bipolar Depression in Adolescents

NCT00841269
completednot_applicable

Uridine Adolescent Bipolar Depression Randomized Controlled Trial

NCT01805440
terminatedphase_1

Immunologic Effects of Supplemental Monosaccharide and Nucleoside Derivatives in Patients With Inherited Disorders of Glycosylation

NCT02511041
completednot_applicable

Study of Uridine Triphosphate (UTP) as an Aerosol Spray for Cystic Fibrosis

NCT00004705
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT03265964Phase 4

Clinical and Imaging Trial of Uridine for Veterans With Suicidal Ideation

Completed
NCT00841269Phase 2

Oral Uridine for Treatment of Bipolar Depression in Adolescents

Completed
NCT01805440Not Applicable

Uridine Adolescent Bipolar Depression Randomized Controlled Trial

Completed
NCT02511041Phase 1

Immunologic Effects of Supplemental Monosaccharide and Nucleoside Derivatives in Patients With Inherited Disorders of Glycosylation

Terminated
NCT00004705Not Applicable

Study of Uridine Triphosphate (UTP) as an Aerosol Spray for Cystic Fibrosis

Completed
NCT01261260Phase 1

Effect of Uridine on GABA and High Energy Phosphate Levels in Healthy Volunteers

Completed
NCT00322764Phase 2

Phase II Study to Assess RG2417 in the Treatment of Bipolar I Depression

Completed
NCT00004658Phase 2

Phase II Study of Ribose, Uridine, and Thymidine for a Complex Syndrome Involving Excessive 5'-Nucleotidase Activity

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8